ESC 2026: oral and injectable GLP-1 comparisons under the spotlight - Pharmaceutical Technology

At ESC 2026, a session presented by Dr Domenica Rubino covered the considerations to take into account when comparing oral and injectable formulations of GLP-1 therapies. At ESC 2026, a session presented by Dr Domenica Rubino covered the considerations to take into account when comparing oral and injectable formulations of GLP-1 therapies. ESC 2026 provided an opportunity to assess the benefits and hurdles of newly launched oral GLP-1RAs. Credit: Love Employee/Shutterstock.com. Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends. With a free Pharmaceutical…

Source: Pharmaceutical Technology